Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
Insider tradingForm 4

Allogene Therapeutics, Inc. (ALLO) Insider Trading

2 open-market trades reported since Aug 25, 2026: 0 purchases worth $0 and 2 sales worth $112K.

By insider

InsiderRoleBuysBoughtSellsSoldLatest
Geoffrey M. ParkerCFO0$01$49KOct 23, 2026
Earl Martin DouglasGeneral Counsel0$01$63KAug 25, 2026
ADVERTISEMENT
728 × 90 ad slot320 × 100 ad slot

All trades

ALLO insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHolding3 mo. afterFiling
Oct 23Oct 21Geoffrey M. ParkerCFOCFO▼ SELL36,3421.34$49K−3.4%Form 4 ↗
Aug 25Aug 21Earl Martin DouglasGeneral CounselGeneral Counsel▼ SELL29,6972.12$63K−5.7%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings